Roche Holding AG RHHBY | OTC
|2026-10-15
Company Overview:
10 Year RHHBY Performance Metrics:
RHHBY Dividend Charts
Unlock All Reports & Research Dividend Stocks like a BOSS!
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
RHHBY Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
Ratios, Profit Margins & Return on Capital:
RHHBY Dividends Info:
RHHBY Dividend History: Dates, Payments & Yield list
Below is a schedule of all RHHBY dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield
| Ex-Date | Payment Date | Amount | Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 03/13/2026 | 04/22/2026 | $1.550 | 3.09% | 3.03% | $51.20 |
| 03/28/2025 | 05/14/2025 | $1.389 | 3.31% | 3.72% | $37.34 |
| 03/14/2024 | 05/03/2024 | $1.349 | 4.1% | 4.52% | $29.83 |
| 03/16/2023 | 03/27/2023 | $1.279 | 3.65% | 3.65% | $35.10 |
| 03/17/2022 | 03/28/2022 | $1.265 | 2.64% | 2.52% | $50.11 |
| 03/18/2021 | 03/29/2021 | $1.278 | 3.12% | 3.17% | $40.38 |
| 03/19/2020 | 03/30/2020 | $1.151 | 2.96% | 2.82% | $40.88 |
| 03/07/2019 | 03/18/2019 | $1.094 | 3.27% | 3.23% | $33.86 |
| 03/15/2018 | 05/04/2018 | $1.113 | 3.82% | 3.94% | $28.23 |
| 03/15/2017 | 05/11/2017 | $1.018 | 3.25% | 3.06% | $33.28 |
| 03/02/2016 | 04/22/2016 | $1.032 | 3.21% | 3.19% | $32.35 |
| 03/04/2015 | 04/20/2015 | $1.084 | 3.27% | 3.04% | $35.62 |
| 03/06/2014 | 04/22/2014 | $1.098 | 2.94% | 3.03% | $36.27 |
| 03/07/2013 | 04/11/2013 | $1.011 | 3.56% | 3.31% | $30.50 |
| 03/08/2012 | 04/12/2012 | $0.930 | 4.28% | 4.32% | $21.52 |
| 03/03/2011 | 04/25/2011 | $0.859 | 4.74% | 4.46% | $19.26 |
| 02/27/2006 | 11/30/-0001 | $0.240 | 1.32% | 1.32% | $18.22 |
| 03/05/2007 | 11/30/-0001 | $0.345 | 1.6% | 1.6% | $21.56 |
| 03/04/2008 | 11/30/-0001 | $0.523 | 2.21% | 2.21% | $23.70 |
| 03/11/2009 | 11/30/-0001 | $0.531 | 3.46% | 3.46% | $15.32 |
| 03/04/2010 | 11/30/-0001 | $0.697 | 3.33% | 3.33% | $20.93 |
| 02/28/2005 | 11/30/-0001 | $0.211 | 1.62% | 1.62% | $13.06 |
Projected Future Returns & Dividends for RHHBY
Based on past 10-year performance, here are RHHBY growth metrics:
Share price CAGR of +6.91%
Dividend CAGR of +4.15%
Using RHHBY CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| RHHBY (DRIP) | RHHBY - No DRIP | |
|---|---|---|
| Current Price | $57.25 | $57.25 |
| Start Shares | 174.67 | 174.67 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 221.70 | 174.67 |
| Dividends Payment | $2.33 | $2.33 |
| Annual Dividends | $516 | $406 |
| Yield on cost | 5.16% | 4.06% |
| Share Price | $111.67 | $111.67 |
| Total Dividends | $3,699 | $3,272 |
| Final Value | $24,757 | $22,778 |
NOTE: Above numbers are our estimate based on RHHBY's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
Company Info
Roche Holding AG (RHHBY) had its IPO on 2003-08-20, and is traded on OTC stock exchange.
Roche Holding AG functions as a major global healthcare enterprise, primarily concentrating its efforts within the pharmaceutical and diagnostic sectors. The company boasts an extensive international presence, with key operations located in countries such as Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, and Belgium. Its pharmaceutical division is dedicated to creating and supplying a diverse array of therapeutic remedies. These target a broad spectrum of medical fields, including oncology, neuroscience, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments. The comprehensive product line further extends to treatments for specific conditions like infectious diseases, anemia, various dermatological issues, hemophilia, inflammatory and autoimmune disorders, neurological conditions, and transplantation-related needs. Within its diagnostics segment, Roche develops and markets a wide variety of laboratory-based tests designed to identify and monitor numerous illnesses. These include, but are not limited to, cancer, diabetes, Covid-19, hepatitis, and human papillomavirus. Additionally, the company is a provider of essential diagnostic instruments and reagents. Established in 1896, Roche Holding AG maintains its corporate headquarters in Basel, Switzerland.
RHHBY website: https://www.roche.com
Get Full Access to All Reports with DRIPCalc PRO
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
DCF Model — RHHBY
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
| Year | FCF | Implied price |
|---|
